Epistatic mutations in PUMA BH3 drive an alternate binding mode to potently and selectively inhibit anti-apoptotic Bfl-1
出版年份 2017 全文链接
标题
Epistatic mutations in PUMA BH3 drive an alternate binding mode to potently and selectively inhibit anti-apoptotic Bfl-1
作者
关键词
-
出版物
eLife
Volume 6, Issue -, Pages -
出版商
eLife Sciences Organisation, Ltd.
发表日期
2017-06-06
DOI
10.7554/elife.25541
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Rapid Optimization of Mcl-1 Inhibitors using Stapled Peptide Libraries Including Non-Natural Side Chains
- (2016) Raheleh Rezaei Araghi et al. ACS Chemical Biology
- hBfl-1/hNOXA Interaction Studies Provide New Insights on the Role of Bfl-1 in Cancer Cell Resistance and for the Design of Novel Anticancer Agents
- (2016) Elisa Barile et al. ACS Chemical Biology
- iBH3: simple, fixable BH3 profiling to determine apoptotic priming in primary tissue by flow cytometry
- (2016) Jeremy Ryan et al. BIOLOGICAL CHEMISTRY
- Designing helical peptide inhibitors of protein–protein interactions
- (2016) Raheleh Rezaei Araghi et al. CURRENT OPINION IN STRUCTURAL BIOLOGY
- The MCL1 inhibitor S63845 is tolerable and effective in diverse cancer models
- (2016) András Kotschy et al. NATURE
- Biophysical determinants for cellular uptake of hydrocarbon-stapled peptide helices
- (2016) Gregory H Bird et al. Nature Chemical Biology
- Targeting BCL2 with Venetoclax in Relapsed Chronic Lymphocytic Leukemia
- (2016) Andrew W. Roberts et al. NEW ENGLAND JOURNAL OF MEDICINE
- Hierarchy and extremes in selections from pools of randomized proteins
- (2016) Sébastien Boyer et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Electrophilic Helical Peptides That Bond Covalently, Irreversibly, and Selectively in a Protein–Protein Interaction Site
- (2016) Aline Dantas de Araujo et al. ACS Medicinal Chemistry Letters
- Defining specificity and on-target activity of BH3-mimetics using engineered B-ALL cell lines
- (2016) Brian Koss et al. Oncotarget
- Computationally designed high specificity inhibitors delineate the roles of BCL2 family proteins in cancer
- (2016) Stephanie Berger et al. eLife
- Drug-Induced Death Signaling Strategy Rapidly Predicts Cancer Response to Chemotherapy
- (2015) Joan Montero et al. CELL
- Attacking cancer's Achilles heel: antagonism of anti-apoptotic BCL-2 family members
- (2015) Joseph T. Opferman FEBS Journal
- Role of the pro-survival molecule Bfl-1 in melanoma
- (2015) C.K. Hind et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Potent and Specific Peptide Inhibitors of Human Pro-Survival Protein Bcl-x L
- (2015) Sanjib Dutta et al. JOURNAL OF MOLECULAR BIOLOGY
- Locating Herpesvirus Bcl-2 Homologs in the Specificity Landscape of Anti-Apoptotic Bcl-2 Proteins
- (2015) Glenna Wink Foight et al. JOURNAL OF MOLECULAR BIOLOGY
- Designed BH3 Peptides with High Affinity and Specificity for Targeting Mcl-1 in Cells
- (2014) Glenna Wink Foight et al. ACS Chemical Biology
- Genome-Wide Prediction and Validation of Peptides That Bind Human Prosurvival Bcl-2 Proteins
- (2014) Joe DeBartolo et al. PLoS Computational Biology
- Peptide Ligands for Pro-survival Protein Bfl-1 from Computationally Guided Library Screening
- (2013) Sanjib Dutta et al. ACS Chemical Biology
- Multimodal Interaction with BCL-2 Family Proteins Underlies the Proapoptotic Activity of PUMA BH3
- (2013) Amanda L. Edwards et al. CHEMISTRY & BIOLOGY
- Evaluation of the BH3-only Protein Puma as a Direct Bak Activator
- (2013) Haiming Dai et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- BH3 profiling in whole cells by fluorimeter or FACS
- (2013) Jeremy Ryan et al. METHODS
- Structure-guided design of a selective BCL-XL inhibitor
- (2013) Guillaume Lessene et al. Nature Chemical Biology
- ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets
- (2013) Andrew J Souers et al. NATURE MEDICINE
- BCL2A1is a lineage-specific antiapoptotic melanoma oncogene that confers resistance to BRAF inhibition
- (2013) Rizwan Haq et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- In Silico and in Vitro Elucidation of BH3 Binding Specificity toward Bcl-2
- (2012) Nir London et al. BIOCHEMISTRY
- Phase II Study of Single-Agent Navitoclax (ABT-263) and Biomarker Correlates in Patients with Relapsed Small Cell Lung Cancer
- (2012) C. M. Rudin et al. CLINICAL CANCER RESEARCH
- Predictive Bcl-2 Family Binding Models Rooted in Experiment or Structure
- (2012) Joe DeBartolo et al. JOURNAL OF MOLECULAR BIOLOGY
- Structure-Based Redesign of the Binding Specificity of Anti-Apoptotic Bcl-xL
- (2012) T. Scott Chen et al. JOURNAL OF MOLECULAR BIOLOGY
- Selective Induction of Cell Death in Melanoma Cell Lines through Targeting of Mcl-1 and A1
- (2012) Daniela Senft et al. PLoS One
- Bcl-xL-inhibitory BH3 mimetics can induce a transient thrombocytopathy that undermines the hemostatic function of platelets
- (2011) S. M. Schoenwaelder et al. BLOOD
- Mutation to Bax beyond the BH3 Domain Disrupts Interactions with Pro-survival Proteins and Promotes Apoptosis
- (2011) Peter E. Czabotar et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Substantial Susceptibility of Chronic Lymphocytic Leukemia to BCL2 Inhibition: Results of a Phase I Study of Navitoclax in Patients With Relapsed or Refractory Disease
- (2011) Andrew W. Roberts et al. JOURNAL OF CLINICAL ONCOLOGY
- Pretreatment Mitochondrial Priming Correlates with Clinical Response to Cytotoxic Chemotherapy
- (2011) T. N. Chonghaile et al. SCIENCE
- Features and development ofCoot
- (2010) P. Emsley et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- PHENIX: a comprehensive Python-based system for macromolecular structure solution
- (2010) Paul D. Adams et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- Inhibition of Bfl-1 with N-aryl maleimides
- (2010) John R. Cashman et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Defective ubiquitin-mediated degradation of antiapoptotic Bfl-1 predisposes to lymphoma
- (2010) G. Fan et al. BLOOD
- Determinants of BH3 Binding Specificity for Mcl-1 versus Bcl-xL
- (2010) Sanjib Dutta et al. JOURNAL OF MOLECULAR BIOLOGY
- Heightened mitochondrial priming is the basis for apoptotic hypersensitivity of CD4+ CD8+ thymocytes
- (2010) J. A. Ryan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Mcl-1-Bim complexes accommodate surprising point mutations via minor structural changes
- (2010) Emiko Fire et al. PROTEIN SCIENCE
- Conformational Changes in Bcl-2 Pro-survival Proteins Determine Their Capacity to Bind Ligands
- (2009) Erinna F. Lee et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- DNA fingerprinting of the NCI-60 cell line panel
- (2009) P. L. Lorenzi et al. MOLECULAR CANCER THERAPEUTICS
- MYC-induced myeloid leukemogenesis is accelerated by all six members of the antiapoptotic BCL family
- (2009) L J Beverly et al. ONCOGENE
- Completing the family portrait of the anti-apoptotic Bcl-2 proteins: Crystal structure of human Bfl-1 in complex with Bim
- (2008) Maria Dolores Herman et al. FEBS LETTERS
- Gambogic acid is an antagonist of antiapoptotic Bcl-2 family proteins
- (2008) Dayong Zhai et al. MOLECULAR CANCER THERAPEUTICS
- Hydrophile scanning as a complement to alanine scanning for exploring and manipulating protein-protein recognition: Application to the Bim BH3 domain
- (2008) Melissa D. Boersma et al. PROTEIN SCIENCE
- Structural Plasticity Underpins Promiscuous Binding of the Prosurvival Protein A1
- (2008) Callum Smits et al. STRUCTURE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More